Search hospitals > New Jersey > Hackensack
Hackensack University Medical Center
Claim this profileHackensack, New Jersey 07601
Global Leader in Lymphoma
Global Leader in Cancer
Conducts research for Adult T-Cell Leukemia/Lymphoma
Conducts research for Parotid Gland Cancer
Conducts research for Multiple Myeloma
982 reported clinical trials
52 medical researchers
Summary
Hackensack University Medical Center is a medical facility located in Hackensack, New Jersey. This center is recognized for care of Lymphoma, Cancer, Adult T-Cell Leukemia/Lymphoma, Parotid Gland Cancer, Multiple Myeloma and other specialties. Hackensack University Medical Center is involved with conducting 982 clinical trials across 1,006 conditions. There are 52 research doctors associated with this hospital, such as Martin E Gutierrez, Katharine Offer, Burton E. Appel, and Derek Hanson, MD.Area of expertise
1Lymphoma
Global LeaderStage IV
Stage III
Stage II
2Cancer
Global LeaderStage IV
Stage III
Stage I
Top PIs
Martin E GutierrezJohn Theurer Cancer Center at Hackensack University Medical Center3 years of reported clinical research
Expert in Cancer
Expert in Solid Tumors
48 reported clinical trials
85 drugs studied
Katharine OfferHackensack University Medical Center8 years of reported clinical research
Expert in Cancer
Expert in Osteosarcoma
35 reported clinical trials
67 drugs studied
Burton E. AppelHackensack University Medical Center5 years of reported clinical research
Studies Lymphoma
Studies Adult T-Cell Leukemia/Lymphoma
23 reported clinical trials
60 drugs studied
Derek Hanson, MDHackensack University Medical Center3 years of reported clinical research
Studies Brain Tumor
Studies Brain Cancer
17 reported clinical trials
38 drugs studied
Clinical Trials running at Hackensack University Medical Center
Breast Cancer
Lymphoma
Cancer
Parotid Gland Cancer
Bladder Cancer
Prostate Cancer
Multiple Myeloma
Testicular cancer
Brain Tumor
Lung Cancer
Low Dose Tamoxifen
for Breast Cancer
This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy to treat postmenopausal women with hormone-dependent breast cancer. Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer.
Recruiting2 awards Phase 38 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Hackensack University Medical Center?
Where is Hackensack University Medical Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does Hackensack University Medical Center accept?
What awards or recognition has Hackensack University Medical Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.